Antibody-drug conjugates: A developing market with substantial growth potential

20:48 PM | January 20, 2014 | —Deepti Ramesh

The antibody-drug conjugates (ADCs) market, which is in its early stages of development, offers growth opportunities for several contract-manufacturing organizations (CMOs).